Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nol-Index Guided Remifentanil Analgesia Versus Standard Analgesia During Moderate-to-High Risk Cardiovascular Surgery: a Randomized Controlled Trial

NCT04137991 is registered in ClinicalTrials.gov with Erasme University Hospital as lead sponsor.

NCT NCT04137991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04137991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nol-Index Guided Remifentanil Analgesia Versus Standard Analgesia During Moderate-to-High Risk Cardiovascular Surgery: a Randomized Controlled Trial
Lead sponsor
Erasme University Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 10, 2019
Completion date
November 1, 2021
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery, general anesthesia, goal-directed therapy, hemodynamic instability, nociceptive pain, nol-index, remifentanil, vascular surgery